Eleana Tsoumani

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark.

Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: July 09, 2026

Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65-84 years of age in Belgium: An epidemiological modeling study.

Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65-84 years of age in Belgium: An epidemiological modeling study.

Journal: Human vaccines & immunotherapeutics

Published: March 20, 2026

Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Journal: Journal of medical economics

Published: February 18, 2026

Estimating the Health and Economic Burden of Pneumococcal Diseases Attributable to PCV21 Versus PCV20 or PPSV23 Serotypes Among Adults in Norway.

Estimating the Health and Economic Burden of Pneumococcal Diseases Attributable to PCV21 Versus PCV20 or PPSV23 Serotypes Among Adults in Norway.

Journal: Infectious diseases and therapy

Published: October 03, 2025

Serotype-specific incidence and comparative vaccine coverage of invasive pneumococcal disease among adults ≥65 years of age in European countries from 2011 to 2023.

Serotype-specific incidence and comparative vaccine coverage of invasive pneumococcal disease among adults ≥65 years of age in European countries from 2011 to 2023.

Journal: Vaccine

Published: September 29, 2025

Sex differences in the impact of lower respiratory tract infections on older adults' health trajectories: a population-based cohort study.

Sex differences in the impact of lower respiratory tract infections on older adults' health trajectories: a population-based cohort study.

Journal: BMC infectious diseases

Published: August 23, 2024

Impact of lower-respiratory tract infections on healthcare utilization and mortality in older adults: a Swedish population-based cohort study.

Impact of lower-respiratory tract infections on healthcare utilization and mortality in older adults: a Swedish population-based cohort study.

Journal: Aging clinical and experimental research

Published: May 22, 2024

Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature.

Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature.

Journal: Human vaccines & immunotherapeutics

Published: November 28, 2023

Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland.

Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland.

Journal: Vaccine

Published: November 18, 2023

Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.

Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.

Journal: Expert review of vaccines

Published: October 12, 2023

Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study.

Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study.

Journal: Expert review of vaccines

Published: December 15, 2022

Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.

Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.

Journal: PloS one

Published: October 31, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026